Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Medtronic
Healthtrust
Julphar
Accenture
Cantor Fitzgerald
Fish and Richardson
Covington
Chubb
Farmers Insurance

Generated: January 16, 2019

DrugPatentWatch Database Preview

MINOCIN Drug Profile

« Back to Dashboard

When do Minocin patents expire, and when can generic versions of Minocin launch?

Minocin is a drug marketed by Precision Dermat, Triax Pharms, Lederle, and Rempex Pharms. and is included in five NDAs. There are two patents protecting this drug.

This drug has twenty-seven patent family members in twenty-one countries.

The generic ingredient in MINOCIN is minocycline hydrochloride. There are fourteen drug master file entries for this compound. Fifty-three suppliers are listed for this compound. Additional details are available on the minocycline hydrochloride profile page.

Summary for MINOCIN
International Patents:27
US Patents:2
Applicants:4
NDAs:5
Suppliers / Packagers: 5
Bulk Api Vendors: 38
Clinical Trials: 34
Patent Applications: 9,540
Formulation / Manufacturing:see details
Drug Prices: Drug price information for MINOCIN
DailyMed Link:MINOCIN at DailyMed
Drug patent expirations by year for MINOCIN
Pharmacology for MINOCIN
Drug ClassTetracycline-class Drug
Medical Subject Heading (MeSH) Categories for MINOCIN
Anti-Bacterial Agents
Synonyms for MINOCIN
(2E,4S,4aR,5aS,12aR)-2-(amino-hydroxy-methylidene)-4,7-bis(dimethylamino)-10,11,12a-trihydroxy-4a,5,5a,6-tetrahydro-4H-tetracene-1,3 ,12-trione
(2E,4S,4AS,5AR,12AS)-2-[AMINO(HYDROXY)METHYLIDENE]-4,7-BIS(DIMETHYLAMINO)-10,11,12A-TRIHYDROXY-1,2,3,4,4A,5,5A,6,12,12A-DECAHYDROTETRACENE-1,3,12-TRIONE
(2E,4S,4aS,5aR,12aS)-2-[amino(hydroxy)methylidene]-4,7-bis(dimethylamino)-10,11,12a-trihydroxy-4a,5,5a,6-tetrahydro-4H-tetracene-1,3,12-trione
(2Z,4S,4aS,5aR,12aS)-2-[amino(hydroxy)methylidene]-4,7-bis(dimethylamino)-10,11,12a-trihydroxy-4a,5,5a,6-tetrahydro-4H-tetracene-1,3,12-trione
(4S,4aS,5aR,12aS)-2-[amino(hydroxy)methylidene]-4,7-bis(dimethylamino)-10,11,12a-trihydroxy-4a,5,5a,6-tetrahydro-4H-tetracene-1,3,12-trione
(4S,4AS,5AR,12AS)-4,7-BIS(DIMETHYLAMINO)-3,10,12,12A-TETRAHYDROXY-1,11-DIOXO-1,4,4A,5,5A,6,11,12A-OCTAHYDROTETRACENE-2-CARBOXAMIDE
(4S,4aS,5aR,12aS)-4,7-bis(dimethylamino)-3,10,12,12a-tetrahydroxy-1,11-dioxo-4a,5,5a,6-tetrahydro-4H-tetracene-2-carboxamide
(4S,4aS,5aR,12aS)4,7-Bis(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,10,12,12a-tetrahydroxy-1,11-dioxonaphthacene-2-carboxamide;(4S,4aS,5aR,12aS)4,7-Bis(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,10,12,12a-tetrahydro
10118-90-8
1071761-03-9
13614-98-7 (mono-hydrochloride)
1371-EP2269978A2
1371-EP2269985A2
1371-EP2269991A2
1371-EP2272832A1
1371-EP2284150A2
1371-EP2284151A2
1371-EP2284152A2
1371-EP2284153A2
1371-EP2284155A2
1371-EP2284156A2
1371-EP2284164A2
1371-EP2287140A2
1371-EP2287148A2
1371-EP2287150A2
1371-EP2289871A1
1371-EP2292590A2
1371-EP2292612A2
1371-EP2295402A2
1371-EP2295419A2
1371-EP2295426A1
1371-EP2295427A1
1371-EP2298732A1
1371-EP2301534A1
1371-EP2301912A2
1371-EP2301913A1
1371-EP2301914A1
1371-EP2301916A2
1371-EP2305637A2
1371-EP2308832A1
1371-EP2308863A1
1371-EP2311451A1
1371-EP2311796A1
1371-EP2311797A1
1371-EP2311798A1
1371-EP2311799A1
1371-EP2316450A1
146440-73-5
17175-40-5
18M908
2-Naphthacenecarboxamide, 4,7-bis(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,10,12,12a-tetrahydroxy-1,11-dioxo-, (4S-(4alpha,4aalpha,5aalpha,12aalpha))-
2-Naphthacenecarboxamide, 4,7-bis(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,10,12,12a-tetrahydroxy-1,11-dioxo-, (4S,4aS,5aR,12aS)-
24058-90-0
4,7-Bis(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,10,12,12a-tetrahydroxy-1,11-dioxo-2-naphthacenecarboxamide
7-Dimethylamino-6-demethyl-6-deoxytetracycline
AB00053501_04
AB00053501_05
AB00053501-03
AC1L2NSN
AC1NQXWM
AC1NSG0A
AJ-65483
AK322058
Akamin
Aknemin
AKOS015969674
Alti-Minocycline
AM20090714
API0003397
Apo-Minocycline
Arestin
BCBcMAP01_000027
BCP9000928
BDBM50103599
Bio-0062
Borymycin
BRN 3077644
BSPBio_002035
C07225
C23H27N3O7
CAS-10118-90-8
CHEBI:50694
CHEMBL1434
CHEMBL259172
CL 59806
CRL-1605 & Minocycline
D05045
D08LTU
DB01017
DivK1c_000450
DSSTox_CID_25033
DSSTox_GSID_45033
DSSTox_RID_80650
DTXSID1045033
DYKFCLLONBREIL-KVUCHLLUSA-N
Dynacin
FT-0628949
FYY3R43WGO
Gen-Minocycline
HMS2090D03
HSDB 3130
IDI1_000450
J-500789
KBio1_000450
KBio2_001447
KBio2_004015
KBio2_006583
KBio3_001535
KBioGR_000583
KBioSS_001447
Klinomycin
KSC-12-231B
KUC106429N
Lactoferrin B & Minocycline
Lactoferrin H & Minocycline
LMPK07000002
LS-93850
MINO
Mino-Tabs
Minociclina
Minociclina [INN-Spanish]
minociclinum
Minocin (Hydrochloride)
Minocin (TN)
Minocline
Minocyclin
minocycline
Minocycline (USAN/INN)
Minocycline [USAN:BAN:INN]
Minocycline [USAN:INN:BAN]
Minocycline Monohydrochloride
Minocyclinum
Minocyclinum [INN-Latin]
Minocyn
Minoderm
Minoz
MIY
MolPort-020-005-814
NCGC00178854-01
NCGC00183044-01
NCGC00188954-01
NINDS_000450
Novo-Minocycline
NSC 141993
NSC141993
PL009220
PL045106
Prestwick0_000315
Prestwick1_000315
Prestwick2_000315
SBI-0051449.P003
SCHEMBL16681149
SCHEMBL24315
SCHEMBL4042
Sebomin
SMP1_000191
Solodyn
SPBio_000974
SPBio_002529
Spectrum_000967
Spectrum2_001047
Spectrum3_000508
Spectrum4_000062
Spectrum5_001293
Tox21_113643
Tri-minocycline
UNII-FYY3R43WGO
Vectrin
Vectrin (Hydrochloride)
ZINC100409820
ZINC14879992
ZINC4019704

US Patents and Regulatory Information for MINOCIN

Glossary
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Precision Dermat MINOCIN minocycline hydrochloride CAPSULE;ORAL 050649-001 May 31, 1990 AB RX Yes No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Rempex Pharms MINOCIN minocycline hydrochloride INJECTABLE;INJECTION 050444-001 Approved Prior to Jan 1, 1982 RX Yes Yes ➤ Sign Up ➤ Sign Up ➤ Sign Up
Triax Pharms MINOCIN minocycline hydrochloride CAPSULE;ORAL 050315-002 Approved Prior to Jan 1, 1982 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Rempex Pharms MINOCIN minocycline hydrochloride INJECTABLE;INJECTION 050444-001 Approved Prior to Jan 1, 1982 RX Yes Yes ➤ Sign Up ➤ Sign Up ➤ Sign Up
Precision Dermat MINOCIN minocycline hydrochloride CAPSULE;ORAL 050649-003 Feb 12, 2001 DISCN Yes No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Precision Dermat MINOCIN minocycline hydrochloride CAPSULE;ORAL 050649-002 May 31, 1990 AB RX Yes No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Lederle MINOCIN minocycline hydrochloride INJECTABLE;INJECTION 062139-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Merck
UBS
Fuji
Covington
Chubb
Colorcon
McKesson
Cerilliant
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2019 thinkBiotech LLC
ISSN: 2162-2639
Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions
Site Map
Major Patent Expirations 2019 - 2020
Preferred Citation:
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2019, www.DrugPatentWatch.com.
Links

Follow DrugPatentWatch: